5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.12▼ | 1.12▼ | 1.12▼ | 1.14▼ | 1.31▼ |
MA10 | 1.16▼ | 1.16▼ | 1.15▼ | 1.19▼ | 1.49▼ |
MA20 | 1.16▼ | 1.15▼ | 1.16▼ | 1.31▼ | 1.67▼ |
MA50 | 1.22▼ | 1.27▼ | 1.31▼ | 1.55▼ | N/A |
MA100 | 1.32▼ | 1.36▼ | 1.39▼ | 1.68▼ | N/A |
MA200 | 1.41▼ | 1.58▼ | 1.67▼ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | 0.000▲ | 0.001▲ | -0.013▼ | N/A |
RSI | 35.921▼ | 33.773▼ | 33.855▼ | 33.652▼ | 31.661▼ |
STOCH | 3.509▼ | 3.509▼ | 3.509▼ | 19.405▼ | 10.811▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -86.916▼ | -94.853▼ |
CCI | -96.552 | -93.825 | -95.582 | -85.450 | -131.097▼ |
Thursday, July 31, 2025 11:43 AM
The Buy rating indicates UBS expects RTX to outperform the broader market, driven by both internal execution and broader tailwinds in defense spending and commercial travel recovery. Still, potential ...
|
Wednesday, July 30, 2025 05:39 AM
Financing designed to support Phase 2 IPF trial and pipeline advancementAUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company ...
|
Tuesday, July 29, 2025 01:01 PM
We recently published 12 Stocks Jim Cramer Discussed As He Said “Pilots Are Too Expensive”. RTX Corporation (NYSE:RTX) is one of the stocks Jim Cramer recently discussed. Defense contractor RTX ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 1.12 | 1.14 | 1.06 | 1.11 | 35,041 |
07/08/25 | 1.16 | 1.16 | 1.10 | 1.11 | 37,200 |
06/08/25 | 1.17 | 1.20 | 1.13 | 1.155 | 12,500 |
05/08/25 | 1.12 | 1.24 | 1.12 | 1.18 | 44,300 |
04/08/25 | 1.10 | 1.15 | 1.04 | 1.12 | 48,000 |
01/08/25 | 1.165 | 1.18 | 1.11 | 1.11 | 24,900 |
31/07/25 | 1.27 | 1.32 | 1.051 | 1.165 | 362,491 |
30/07/25 | 1.37 | 1.39 | 1.26 | 1.27 | 34,100 |
29/07/25 | 1.38 | 1.38 | 1.25 | 1.25 | 26,000 |
28/07/25 | 1.46 | 1.46 | 1.39 | 1.41 | 11,708 |
|
|
||||
|
|
||||
|
|